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Mitochondrial proteases strike the right balance
M
itochondria constantly merge 
and divide to share compo-
nents and alter their cellular 
distribution. Maintaining the correct 
balance between fi  ssion and fusion is so 
important that at least three proteases 
converge to regulate a key fusion pro-
tein, as studies from Ehses et al. and 
Head et al. now show (1, 2).
Fusion between mitochondria is 
mediated by GTPases related to the endo-
cytic  protein dynamin. Inner membrane 
fusion is controlled by the OPA1 GTPase, 
which exists as a carefully attuned mixture 
of long and short isoforms that are both 
required for membrane fusion (3, 4). 
The balance between OPA1 versions is 
maintained in part by a protease called 
YME1L, which cleaves long OPA1 to 
generate the shorter form (3, 5). But the 
situation is complicated by the existence 
of OPA1 splice variants that can’t be 
cleaved by YME1L, and by the fact that 
stress induces the complete cleavage of all 
long OPA1 so that fusion is blocked and 
cells can separate damaged mitochondria 
from their healthier kin (5).
This suggests that OPA1 may be 
cleaved by other proteases too. The 
multi-subunit  m-AAA protease has 
been implicated (6), but the loss of one 
of its subunits, paraplegin, 
doesn’t affect mitochon-
drial dynamics. Thomas 
Langer, from the Univer-
sity of Cologne, Germany, 
decided to investigate the 
role of two homologous 
subunits, AFG3L1 and 
AFG3L2, which can form a 
functional m-AAA protease 
without paraplegin (1).
Knocking down either protein alone 
had no effect on fi  broblasts, but depleting 
both at the same time caused the mitochon-
drial network to fragment due to a block in 
organelle fusion. Accordingly, the balance 
of long and short OPA1 was disrupted in 
cells lacking AFG3L1 and AFG3L2, al-
though not in the way one might expect. 
Rather than accumulating, levels of long 
OPA1 actually decreased in the absence of 
the m-AAA protease subunits. Long OPA1 
was also destabilized in the brain, heart, 
and kidney of mice lacking AFG3L2.
“This really puzzled us for a long 
time,” admits Langer. “But it turns out 
that there’s another mitochondrial protease 
that takes over [in the absence of the 
m-AAA protease].” Activation of this ad-
ditional enzyme—called OMA1—leads 
to the unregulated degradation of all long 
OPA1, blocking fusion and fragmenting 
the mitochondrial network.
Meanwhile, a second team led by 
Alexander van der Bliek from UCLA 
had also discovered that 
OMA1 cleaves OPA1. 
van der Bliek’s group had 
been searching for the 
protease that cuts up the 
fusion protein to prevent 
dysfunctional mitochon-
dria from sharing their 
damaged proteins with 
healthier neighbors. Like 
Langer’s team, they found 
that knocking down OMA1 prevented 
OPA1 from being cleaved in response to 
a loss of mitochondrial membrane po-
tential or depletion of ATP (2). “While 
YME1L cleaves OPA1 to regulate the 
balance of short and long forms, OMA1 
gets rid of long OPA1 to block fusion,” 
says van der Bliek. Langer agrees, adding 
that the m-AAA protease is also involved 
in maintaining the constitutive balance 
of OPA1 isoforms.
Regulating mitochondrial dynam-
ics is clearly critical to a cell’s health, 
particularly within the nervous system. 
Mutations in OPA1 cause dominant 
optic atrophy, while the outer mem-
brane fusion protein MFN2 is linked to 
Charcot-Marie-Tooth disease. The m-AAA 
protease can now be added to the list, 
because mutations in AFG3L2 cause spi-
nocerebellar ataxia.
The next big question is how OMA1 
senses mitochondrial dysfunction—be it 
loss of membrane potential, ATP depletion, 
or absence of the m-AAA protease. Head et 
al. suggest that proteolysis of OMA1 itself 
may be key because a longer, presumably 
active, form of the protease accumulates 
upon mitochondrial damage (2). Under 
normal conditions, this version of OMA1 
would be rapidly turned over. “That might 
seem wasteful,” says van der Bliek. “But 
this would be a quick way to shut fusion 
down and stop damaged mitochondria 
from poisoning the system.”
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Two groups of researchers implicate different mitochondrial 
proteases in the regulation of OPA1, a dynamin-related 
GTPase that promotes mitochondrial inner membrane 
fusion. Ehses et al., led by Thomas Langer (top left), find 
that the m-AAA protease maintains the correct balance 
of long and short OPA1 isoforms—the mitochondrial 
network is fragmented in the absence of two of the 
protease’s subunits (bottom row). Both groups reveal 
that a second protease, OMA1, completely cleaves long 
versions of OPA1 to prevent damaged mitochondria 
from fusing. Brian Head (top right), Lorena Griparic 
(center left), Alexander van der Bliek (center right), 
and colleagues find that OMA1 itself is also regulated 
by proteolysis.
“This would be 





Two studies reveal how proteases combine to regulate mitochondrial fusion.
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